The research and development initiative ‘Innovation Ecosystem Based on the Immune System (InFLAMES)’ has received significant funding from the Academy of Finland.
Keyword: Drug Development and Diagnostics
A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis. This new finding could help in the development of new treatments for Parkinson’s disease.
The University of Turku has entered into a licensing agreement with an international pharma company related to targeting of CIP2A oncoprotein.
A new study conducted in Turku reveals how symptoms indicating depression and anxiety are linked to brain function changes already in healthy individuals.
Opioids regulate the feelings of pleasure and pain in the brain. A study by the national Turku PET Centre shows that age, sex and smoking influence μ-opioid receptor density in the brain. The results of the study help to better understand the differences between individuals when it comes to neuropsychiatric disorders.
Researchers from Ghent University, Belgium, together with researchers from the University of Turku, Finland, have developed a new method for biomarker discovery of urological cancers. The method enables timely diagnosis and treatment of cancer. Urological cancers include e.g. prostate, bladder and kidney cancers.
The virologists at the University of Turku have followed the spread of the novel SARS-CoV-2 virus closely since the beginning of the year. Laboratories in Turku received the first genes of the new virus in February and, ever since, researchers have strived to solve the mysteries of the pathogen only the size of 120 nanometres.
Human emotion system laboratory team at the University of Turku and Turku PET Centre introduces a fully automated method for acute ischemic lesion segmentation on brain MRIs and shows how artificial intelligence can reduce the work load of radiologists.
New study from Eleanor Coffey’s lab at Turku Bioscience Centre in Finland identifies that the JNK protein triggers nerve cells to withdraw their synapses when stressed.
World leading diabetes research foundation JDRF from the United States has granted the University of Turku three-year funding for its PAMP project (Pathogen Associated Molecular Patterns) with the total sum of over €520,000.